ArticleBiometrical journal. Biometrische Zeitschrift2025
Flexible Parametric Accelerated Failure Time Models With Cure.
Article in Biometrical journal. Biometrische Zeitschrift, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Flexible Parametric Accelerated Failure Time Models With Cure.Biometrical journal. Biometrische Zeitschrift · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accelerated failure time (AFT) models offer an attractive alternative to Cox proportional hazards models. AFT models are collapsible and, unlike hazard ratios in proportional hazards models, the acceleration factor-a key effect measure in AFT models-is collapsible, meaning its value remains unchanged when adjusting for additional covariates. In addition, AFT models provide an intuitive interpretation directly on the survival time scale. From the recent development of smooth parametric AFT models, we identify potential issues with their applications and note several desired extensions that have not yet been implemented. To enrich this tool and its application in clinical research, we improve the AFT models within a flexible parametric framework in several ways: we adopt monotone natural splines to constrain the log cumulative hazard to be a monotonic function across its support; allow for time-varying acceleration factors, possibly include cure and accommodating more than one time-varying effect; and implement both mixture and nonmixture cure models. We implement all of these extensions in the rstpm2 package, which is publicly available on CRAN. Simulations highlight a varying success in estimating cure fractions. However, in terms of covariate-effect estimation, flexible AFT models appear to be more robust than the Cox model even when there is a high proportion of cured individuals in the data, regardless of whether cure is reached within the observed data. We also apply some of our extensions of AFT models to real-world survival data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.